Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world setting.

Aarts, Pim; van Huijstee, Johanna C; van der Zee, Hessel H; van Doorn, Martijn B A; van Straalen, Kelsey R; Prens, Errol P

Aarts, Pim; van Huijstee, Johanna C; van der Zee, Hessel H; van Doorn, Martijn B A; van Straalen, Kelsey R; Prens, Errol P.

Afiliación

Aarts P; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: p.aarts@erasmusmc.nl.
van Huijstee JC; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van der Zee HH; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Doorn MBA; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
van Straalen KR; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Prens EP; Department of Dermatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

J Am Acad Dermatol ; 89(4): 677-684, 2023 10.

Article en En | MEDLINE | ID: mdl-37116615

Asunto(s)

Hidradenitis Supurativa; Humanos; Adalimumab; Hidradenitis Supurativa/tratamiento farmacológico; Hidradenitis Supurativa/cirugía; Hidradenitis Supurativa/inducido químicamente; Calidad de Vida; Resultado del Tratamiento; Índice de Severidad de la Enfermedad

Palabras clave

adalimumab; biologics; hidradenitis suppurativa; quality of life; surgery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Hidradenitis Supurativa Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google